Researchers at the University of Cincinnati Gardner Neuroscience Institute's Brain Tumor Center have been confirmed as the ...
Loss of an enzyme necessary for a process called lipoylation disrupts the way cancer cells copy their DNA, increasing their ...
Using a powerful single-molecule imaging method they developed, a Broad Institute research team has unveiled a dynamic view ...
Hosted on MSN
Making sense of your gene expression data
Gene expression analysis helps uncover how cells function, adapt, and contribute to disease. Techniques from microarray preprocessing to advanced single-cell proteomics offer complementary insights ...
At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...
Earlier this year, the largest trial to date on cancer blood tests failed to reach its primary objective. Oncologists haven't ...
Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. A ...
Nanoparticles coated with the molecular sensors could be used in at-home diagnostics. Researchers at MIT and Microsoft have used artificial intelligence to create molecular sensors that could detect ...
BRISBANE, Australia & BOSTON--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced that it has entered ...
Cancer imaging company Kuva Labs is expanding its scope via the acquisition of solid tumor biotech Lisata Therapeutics. The big prize for Kuva is certepetide, Lisata’s cyclic peptide drug that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results